Literature DB >> 4893585

Toxic and therapeutic effects of EMTP in obesity.

D R Hollingsworth, T T Amatruda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4893585     DOI： 10.1002/cpt1969104540

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  3 in total

Review 1.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  Bile acid, neutral sterol and faecal fat excretion in subjects treated with fenfluramine and its relationship to fenfluramine-induced diarrhoea.

Authors:  M S Sian; A J Rains
Journal:  Postgrad Med J       Date:  1979-03       Impact factor: 2.401

3.  Fenfluramine in the treatment of hypertensive patients with refractory obesity.

Authors:  M E Scott; P G Nelson
Journal:  Ulster Med J       Date:  1975
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.